alcyon

/alcyon

About alcyon

This author has not yet filled in any details.
So far alcyon has created 373 blog entries.

Transgene confirme la sécurité et la tolérabilité de TG4001 en combinaison avec avelumab dans la partie Phase 1b d’un essai dans les cancers HPV-positifs

../wp-content/uploads/2019/03/20181220-Phase-1-TG4001-FR-1.pdf

By |2019-03-13T16:49:30+01:00décembre 20th, 2018|Communiqué de presse, TG4001|Commentaires fermés sur Transgene confirme la sécurité et la tolérabilité de TG4001 en combinaison avec avelumab dans la partie Phase 1b d’un essai dans les cancers HPV-positifs

Investigational treatment combining TG1050, an HBV-specific immunotherapeutic, with direct acting antivirals or immunomodulators, improves sustained antiviral effects and immune responses in HBV-persistent mice

Roland Kratzer, et al. AASLD, The Liver Meeting 2018, November [...]

By |2019-07-01T15:33:42+02:00novembre 30th, 2018|Publication, TG1050|Commentaires fermés sur Investigational treatment combining TG1050, an HBV-specific immunotherapeutic, with direct acting antivirals or immunomodulators, improves sustained antiviral effects and immune responses in HBV-persistent mice

Safety and Immunogenicity of Single and Multiple Injections of the Therapeutic Vaccine TG1050 in NUC-Suppressed Chronic Hepatitis B (CHB) Patients: Unblinded Analysis of a Double-Blind, Placebo-Controlled Phase 1b Study

Claire Fournier, et al. AASLD, The Liver Meeting 2018, November [...]

By |2019-07-01T14:15:26+02:00novembre 7th, 2018|Publication, TG1050|Commentaires fermés sur Safety and Immunogenicity of Single and Multiple Injections of the Therapeutic Vaccine TG1050 in NUC-Suppressed Chronic Hepatitis B (CHB) Patients: Unblinded Analysis of a Double-Blind, Placebo-Controlled Phase 1b Study